phase 1
ii 1
study 1
gemcitabine 1
oxaliplatin 2
combination 1
panitumumab 1
kras 1
wildtype 1
unresectable 2
metastatic 1
biliary 2
tract 2
gallbladder 1
cancer 3
emerging 1
treatment 2
options 1
locally 1
advanced 1
pancreatic 1
neoadjuvant 1
leucovorin 1
fluorouracil 1
irinotecan 1
assessment 1
surgical 1
resectability 1
novel 1
agents 1
mantle 1
cell 1
lymphoma 1
